Related Experiment Videos
Protein binding: what does it mean?
1Tufts University School of Medicine, Boston, MA.
DICP : the Annals of Pharmacotherapy
|July 1, 1989
Summary
Drug protein binding significantly impacts how medications work. High binding affects tissue penetration and drug half-life, while low binding leads to faster excretion, influencing clinical effectiveness.
Area of Science:
- Pharmacology
- Drug Metabolism
- Clinical Pharmacy
Background:
- Drug performance is influenced by protein binding.
- High protein binding can limit tissue penetration but prolong half-life.
- Low protein binding enhances tissue penetration but increases excretion rate.
Purpose of the Study:
- To elucidate the clinical significance of drug protein binding.
- To understand how varying degrees of protein binding affect drug pharmacokinetics.
- To highlight the importance of considering protein binding in drug evaluation.
Main Methods:
- Review of pharmacokinetic principles related to drug-protein interactions.
- Analysis of the relationship between protein binding percentage and clinical outcomes.
- Consideration of factors affecting plasma protein concentrations.
Main Results:
- Drugs with <80-85% protein binding show minimal clinical differences.
- Highly protein-bound agents exhibit significant variations in tissue penetration and half-life compared to minimally bound agents.
- Binding to non-albumin plasma proteins can occur.
Conclusions:
- Free drug concentration is a more accurate measure of clinical effect when plasma protein levels fluctuate.
- Clinicians and formulary committees must understand protein binding dynamics for optimal drug selection.
- Qualitative and quantitative differences in protein binding are critical for evaluating drug efficacy.